Personalized app for melanoma survivorship care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized controlled trial evaluates the effectiveness of the Digizorg Melanoma Survivorship Care Plan app for patients diagnosed with stage I and II melanoma. A total of 180 participants will be randomized to receive either the app or usual care, with the app providing tailored healthcare information based on their specific melanoma stage and needs. The study will assess patient empowerment, satisfaction with information and care, and healthcare utilization through questionnaires and medical records over a 12-month period. Additionally, the process of app uptake and implementation will be evaluated through interviews and log-data analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years or older
* Patients who have received a primary diagnosis of cutaneous melanoma stage I to II in the past 0-4 months

Exclusion Criteria:

* Patients with irresectable stage III melanoma, patients receiving neo-adjuvant treatment and patients with stage IV melanoma.
* Patients who do not have (sufficient) command of the Dutch language.

Where it's running

• Albert Schweitzer hospital
  Dordrecht, South Holland, Netherlands Recruiting
• Erasmus MC
  Rotterdam, South Holland, Netherlands Recruiting
• Maasstad hospital
  Rotterdam, South Holland, Netherlands Recruiting
• Franciscus Gasthuis & Vlietland hospital
  Rotterdam, South Holland, Netherlands Not yet recruiting

Study contacts

• Study coordinator: Marjolein Lugtenberg, PhD
• Email: m.lugtenberg@erasmusmc.nl
• Phone: +31614448940

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive training with real-time brain feedback for childhood medulloblastoma survivors

  This study tests whether real-time brain feedback using rt-fMRI or rt-fNIRS can help children and young adults who survived childhood medulloblastoma improve attention and working memory.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07830134

• Hematologic cancer survivors after stem cell transplant try a personalized care plan

  This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Reggio Emilia · NCT07579065

• Support program to improve quality of life for Chinese cancer patients and survivors

  This program will try different mixes of education, counseling, and peer support to see if they help Mandarin-speaking adults with cancer or who have finished treatment feel better.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07454330

• On-Trac: Online training to manage anxiety after cancer

  This program will try an online CBT- and ACT-based education plus brief coaching to help adult cancer survivors manage ongoing anxiety.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07305740

• Improving nasal-sounding speech and swallowing in head and neck cancer survivors with velopharyngeal dysfunction

  This pilot effort tests whether injecting material to 'plump' the back wall of the throat (pharyngeal wall augmentation) can help head and neck cancer survivors with velopharyngeal dysfunction speak less nasally and swallow better.

  Recruiting University of Virginia · Charlottesville, Virginia · NCT07264036

• LiveWell: a tailored DBT skills program for people living with metastatic lung cancer

  This pilot randomized trial tests a telehealth DBT skills program called LiveWell for adults with metastatic non-small cell lung cancer and distress to see if it reduces distress and improves well-being compared to usual care.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07177846

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.